Skip to main content

ABT

ABBOTT LABORATORIES
ShareXLinkedInReddit
Sector
Health Care
Industry
Health Care Equipment
Last price
$93.93
As of

Active signals for ABT

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — ABBOTT Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — ABBOTT PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Tre

  • medtrend_spike

    ABBOTT LABORATORIES search volume spiked +75 pts — unusual interest

  • medtrend_spike

    ABBOTT LABORATORIES search volume spiked +75 pts — unusual interest

  • medtrend_spike

    ABBOTT LABORATORIES search volume spiked +75 pts — unusual interest

Top institutional holders of ABT (13F)

FundMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLC$127.2M0.20%+122.0%
CITADEL ADVISORS LLC$116.8M0.02%,
CITADEL ADVISORS LLC$81.4M0.01%-25.6%
D. E. Shaw & Co., Inc.$70.4M0.04%>5000%
RENAISSANCE TECHNOLOGIES LLC$69.9M0.11%,
MILLENNIUM MANAGEMENT LLC$63.6M0.03%,
MILLENNIUM MANAGEMENT LLC$53.8M0.02%-9.5%
MILLENNIUM MANAGEMENT LLC$47.1M0.02%+6.8%
Bridgewater Associates, LP$16M0.06%,
Bridgewater Associates, LP$15.4M0.06%+2.9%
Bridgewater Associates, LP$12M0.05%-4.6%
D. E. Shaw & Co., Inc.$10.6M0.01%-81.6%
Point72 Asset Management, L.P.$6.5M0.01%+901.6%
SOROS FUND MANAGEMENT LLC$4.6M0.05%,
TWO SIGMA INVESTMENTS, LP$2.7M0.00%,
TWO SIGMA INVESTMENTS, LP$2.1M0.00%,
Point72 Asset Management, L.P.$804K0.00%,
Point72 Asset Management, L.P.$789K0.00%+5.0%
D. E. Shaw & Co., Inc.$335K0.00%,

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, ABT

Related tickers

See more ABT signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track ABT in your watchlist and get notified the moment a new signal fires.

Track ABT on Kresmion →